Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia
Clinical trial NCT05445011 · RECRUITING
Trial details
- NCT number
- NCT05445011
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-14
- Primary completion
- 2025-06-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.